Gavi's evaluation studies

An evaluation is currently under way to assess the relevance, effectiveness and efficiency of technical assistance to countries through Gavi’s partners’ engagement framework (PEF).

This report presents the main findings from an evaluation of Gavi’s support to Albania and its transition after funding ended. The evaluation was conducted by the Curatio International Foundation in 2015.

Gavi’s health system strengthening (HSS) support is regularly evaluated to provide valuable insights into the HSS programme.

This report presents the findings of the Outcomes and Impact evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2015 by The Boston Consulting Group.

This report presents the lessons learnt and recommendations from an independent evaluation of the Gavi co-financing policy conducted by the Norwegian Institute of Public Health in 2014.

This report presents the lessons learnt and recommendations from an evaluation of Gavi’s support to Bosnia and Herzegovina and its transition after funding ended. The evaluation was conducted by the Curatio International Foundation in 2014.

This report presents the findings and lessons from an evaluation of the Gavi-Government of China Hepatitis B vaccination programme. The evaluation was conducted in 2012 by Abt Associates.

Gavi, the Vaccine Alliance launched a new set of evaluations to collect real-time data on immunisation programmes, vaccine-related issues and the contribution of Alliance support in four countries.

This report presents the findings and lessons from an evaluation of the Gavi Gender Policy. The evaluation was conducted in 2012 by ICF Macro, Inc.

This report presents the findings of the Process and Design Evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2012 by Dalberg Global Development Advisors.

This report presents the findings and lessons learnt from a review of the AVI project undertaken by Cambridge Economic Policy Associates for Gavi.

This report presents the findings and lessons learnt from a review of Gavi support to civil society organisations undertaken by Cambridge Economic Policy Associates.

Study of whether IFF concept is proven and whether IFFIm pilot has worked (published 2011).

The Baseline Study for the pneumococcal vaccine Advance Market Commitment establishes the environment prior to the AMC as a basis for future evaluations.

Independent assessment of the Alliance's achievements in Gavi Phase II (published 2010).

Assessing design, execution and results of Independent Review Committees (published 2010).

Complements HSS study; highlights implementation issues in six countries (published 2009).

Study covers 21 countries where HSS had been rolled out by December 2008 (published 2009).

Analysis of sustainability of injection safety support in 58 countries (published 2008).

Independent assessment of the Vaccine Alliance’s achievements in Gavi Phase I (published 2009).

Effectiveness of immunisation services support over its first five years (published 2007).